Likewise, unifying the well-known AD biomarkers MaoB and APOE ε4 with the novel candidates Tm1 and GSTO1 (Table 3) generated a highly disease-specific test (AUC = 0.969). This evidence concerns the gene MAOB and Alzheimer disease.